What is the price target for WHWK stock?
11 analysts have analysed WHWK and the average price target is 5.1 USD. This implies a price increase of 53.61% is expected in the next year compared to the current price of 3.32.
NASDAQ:WHWK • US00032Q1040
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for WHITEHAWK THERAPEUTICS INC (WHWK).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-12-22 | Jones Trading | Initiate | Buy |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 24.354M 60.01% | 25.983M 6.69% | 7.145M -72.50% | -100.00% | 28.9M | 61.88M 114.12% | 130.22M 110.44% | |||||
| EBITDA YoY % growth | -71.764M -22.05% | -64.627M 9.95% | -114.321M -76.89% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -71.933M -22.00% | -64.82M 9.89% | -114.4M -76.49% | -94.436M 17.45% | -99.833M -5.71% | -105.536M -5.71% | -104.244M 1.22% | -107.746M -3.36% | -79.9M 25.84% | -47.26M 40.85% | 36.38M 176.98% | |
| Operating Margin | -295.36% | -249.47% | -1,601.12% | N/A | N/A | N/A | N/A | N/A | -276.47% | -76.37% | 27.94% | |
| EPS YoY % growth | -2.44 10.62% | -2.35 3.69% | -1.73 26.38% | -1.30 24.89% | -1.28 1.30% | N/A | N/A | N/A | N/A | N/A | N/A |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.07 82.36% | -0.31 58.73% | -0.33 -25.54% | -0.33 4.00% |
| Revenue Q2Q % growth | -100.00% | |||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -23.476M -54.27% | -23.178M 57.66% | -23.479M -20.12% | -23.81M 4.33% |
All data in USD
11 analysts have analysed WHWK and the average price target is 5.1 USD. This implies a price increase of 53.61% is expected in the next year compared to the current price of 3.32.
WHITEHAWK THERAPEUTICS INC (WHWK) will report earnings on 2026-05-06.
The consensus EPS estimate for the next earnings of WHITEHAWK THERAPEUTICS INC (WHWK) is -0.07 USD and the consensus revenue estimate is 0 USD.
The number of analysts covering WHITEHAWK THERAPEUTICS INC (WHWK) is 11.